Rhythm Pharmaceuticals Investor Relations Material

Rhythm Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. Rhythm Pharmaceuticals Inc is engaged in developing new approaches to treat obesity and metabolic disease by targeting the liver through its regulatory pathways that correlate with energy balance.